CliffBio

Rockwell Medical

Patent cliffs & loss of exclusivity

A biopharmaceutical company developing treatments that target end-stage renal disease and chronic kidney disease

Company

AngelList URLhttps://angel.co/rockwell-medical
CAGE Code4FL28
Company Operating StatusActive
Contact Page URLhttps://www.rockwellmed.com/contact-us/
Crunchbase URLhttps://www.crunchbase.com/organization/rockwell-medical
Facebook URLhttps://www.facebook.com/pages/category/Pharmaceutical-Company/Rockwell-Medical-2264209840280248/
Full Address30142 Wixom Road Wixom, MI 48393
LinkedIn URLhttps://www.linkedin.com/company/rockwell-medical/

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. TRIFERICFERRIC PYROPHOSPHATE CITRATESmall mol.Apr 2029
  2. TRIFERICFERRIC PYROPHOSPHATE CITRATESmall mol.Apr 2029
  3. TRIFERIC AVNUFERRIC PYROPHOSPHATE CITRATESmall mol.Apr 2029
  4. TRIFERICFERRIC PYROPHOSPHATE CITRATESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.